Arbutus Biopharma is a Canadian biopharmaceutical company based in Vancouver, British Columbia and Warminster, Pennsylvania.
On March 10, 2023, U.S. District Judge Mitchell Goldberg rejected a bid by Moderna to dismiss some of the patent infringement claims brought against the company by Arbutus and its partner, Genevant Sciences.1) 2)